Potentially harmful drug-drug interactions in the elderly: A review

American Journal Geriatric Pharmacotherapy

Volumn 9, Issue 6, 2011, Pages 364-377

  Hines, Lisa E ^a   Murphy, John E ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

drug interactions; elderly

Indexed keywords

ALPRAZOLAM; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIINFECTIVE AGENT; BENZODIAZEPINE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROMYCIN; FELODIPINE; LITHIUM; LOOP DIURETIC AGENT; LORAZEPAM; MACROLIDE; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PAROXETINE; PHENYTOIN; POTASSIUM SPARING DIURETIC AGENT; SULFONYLUREA DERIVATIVE; TAMOXIFEN; THEOPHYLLINE; UNINDEXED DRUG; VERAPAMIL; WARFARIN; ZOLPIDEM;

BREAST CANCER; CANCER RISK; DRUG FATALITY; DRUG INTERACTION; DRUG SURVEILLANCE PROGRAM; ELDERLY CARE; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; PRIORITY JOURNAL; REVIEW;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; DRUG INTERACTIONS; HOSPITALIZATION; HUMANS; PHARMACEUTICAL PREPARATIONS; RISK;

EID: 83555176128     PISSN: 15435946     EISSN: 18767761     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2011.10.004     Document Type: Review

References (91)

1. J.A. Oates The science of drug therapy L.L. Brunton, Goodman & Gilman's The Pharmacological Basis of Therapeutics 11th ed. 2006 McGraw-Hill New York
2. L.M. DuBuske The role of P-glycoprotein and organic anion-transporting polypeptides in drug interactions Drug Saf 28 2005 789 801
3. L. Mallet, A. Spinewine, A. Huang The challenge of managing drug interactions in elderly people Lancet 370 2007 185 191 (Pubitemid 47042897)
4. B.J. Cusack Pharmacokinetics in older persons Am J Geriatr Pharmacother 2 2004 274 302 (Pubitemid 40378782)
5. J.J. Crowley, B.J. Cusack, S.G. Jue et al. Aging and drug interactions. II. Effect of phenytoin and smoking on the oxidation of theophylline and cortisol in healthy men J Pharmacol Exp Ther 245 1988 513 523
6. C.M. Loi, B.M. Parker, B.J. Cusack, R.E. Vestal Aging and drug interactions. III. Individual and combined effects of cimetidine and cimetidine and ciprofloxacin on theophylline metabolism in healthy male and female nonsmokers J Pharmacol Exp Ther 280 1997 627 637 (Pubitemid 27171322)
7. R.E. Vestal, B.J. Cusack, J.J. Crowley, C.M. Loi Aging and the response to inhibition and induction of theophylline metabolism Exp Gerontol 28 1993 421 433 (Pubitemid 23226559)
8. R.E. Vestal, B.J. Cusack, G.D. Mercer et al. Aging and drug interactions. I. Effect of cimetidine and smoking on the oxidation of theophylline and cortisol in healthy men J Pharmacol Exp Ther 241 1987 488 500 (Pubitemid 17111553)
9. U. Klotz Pharmacokinetics and drug metabolism in the elderly Drug Metab Rev 41 2009 67 76
10. M.W. Bowie, P.W. Slattum Pharmacodynamics in older adults: a review Am J Geriatr Pharmacother 5 2007 263 303 (Pubitemid 350048507)
11. I.K. Bjorkman, J. Fastbom, I.K. Schmidt, C.B. Bernsten Drugdrug interactions in the elderly Ann Pharmacother 36 2002 1675 1681
12. S.N. Hastings, K.E. Schmader, R.J. Sloane et al. Quality of pharmacotherapy and outcomes for older veterans discharged from the emergency department J Am Geriatr Soc 56 2008 875 880 (Pubitemid 351652387)
13. K. Johnell, I. Klarin The relationship between number of drugs and potential drugdrug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register Drug Saf 30 2007 911 918 (Pubitemid 47481446)
14. D.M. Qato, G.C. Alexander, R.M. Conti et al. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States JAMA 300 2008 2867 2878
15. J.C. Delafuente, R.B. Stewart Therapeutics in the Elderly 3rd ed. 2001 Harvey Whitney Books Cincinnati, Oh
16. J.C. Delafuente Understanding and preventing drug interactions in elderly patients Crit Rev Oncol Hematol 48 2003 133 143 (Pubitemid 37357294)
17. J.T. Hanlon, K.E. Schmader Drugdrug interactions in older adults: which ones matter? Am J Geriatr Pharmacother 3 2005 61 63 (Pubitemid 41200507)
18. E. von Elm, D.G. Altman, M. Egger et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies PLoS Med 4 2007 e296
19. D.N. Juurlink, M. Mamdani, A. Kopp et al. Drugdrug interactions among elderly patients hospitalized for drug toxicity JAMA 289 2003 1652 1658 (Pubitemid 37430270)
20. T. Antoniou, T. Gomes, D.N. Juurlink et al. Trimethoprimsulfamethoxazoleinduced hyperkalemia in patients receiving inhibitors of the reninangiotensin system: a populationbased study Arch Intern Med 170 2010 1045 1049
21. K. Zint, W.E. Haefeli, R.J. Glynn et al. Impact of drug interactions, dosage, and duration of therapy on the risk of hip fracture associated with benzodiazepine use in older adults Pharmacoepidemiol Drug Saf 19 2010 1248 1255
22. A.J. Wright, T. Gomes, M.M. Mamdani et al. The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers CMAJ 183 2011 303 307
23. T. Gomes, M.M. Mamdani, D.N. Juurlink Macrolide-induced digoxin toxicity: a populationbased study Clin Pharmacol Ther 86 2009 383 386
24. A.L. Chan, M.T. Wang, C.Y. Su, F.H. Tsai Risk of digoxin intoxication caused by clarithromycindigoxin interactions in heart failure patients: a populationbased study Eur J Clin Pharmacol 65 2009 1237 1243
25. D.N. Juurlink, M.M. Mamdani, A. Kopp et al. Druginduced lithium toxicity in the elderly: a populationbased study J Am Geriatr Soc 52 2004 794 798 (Pubitemid 38596502)
26. T. Antoniou, T. Gomes, M.M. Mamdani, D.N. Juurlink Trimethoprim/ sulfamethoxazoleinduced phenytoin toxicity in the elderly: a populationbased study Br J Clin Pharmacol 71 2011 544 549
27. H. Schelleman, W.B. Bilker, C.M. Brensinger et al. Antiinfectives and the risk of severe hypoglycemia in users of glipizide or glyburide Clin Pharmacol Ther 88 2010 214 222
28. C.M. Kelly, D.N. Juurlink, T. Gomes et al. Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study BMJ 340 2010 c693
29. T. Antoniou, T. Gomes, M.M. Mamdani, D.N. Juurlink Ciprofloxacininduced theophylline toxicity: a populationbased study Eur J Clin Pharmacol 67 2011 521 526
30. H. Schelleman, W.B. Bilker, C.M. Brensinger et al. Warfarin with fluoroquinolones, sulfonamides, or azole antifungals: interactions and the risk of hospitalization for gastrointestinal bleeding Clin Pharmacol Ther 84 2008 581 588
31. H.D. Fischer, D.N. Juurlink, M.M. Mamdani et al. Hemorrhage during warfarin therapy associated with cotrimoxazole and other urinary tract antiinfective agents: a populationbased study Arch Intern Med 170 2010 617 621
32. M. Battistella, M.M. Mamdami, D.N. Juurlink et al. Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX2 inhibitors Arch Intern Med 165 2005 189 192
33. T.C. Cheetham, G. Levy, F. Niu, F. Bixler Gastrointestinal safety of nonsteroidal antiinflammatory drugs and selective cyclooxygenase2 inhibitors in patients on warfarin Ann Pharmacother 43 2009 1765 1773
34. B.F. Palmer Managing hyperkalemia caused by inhibitors of the reninangiotensinaldosterone system N Engl J Med 351 2004 585 592
35. N. Lam, M.A. Weir, D.N. Juurlink et al. Hospital admissions for hyperkalemia with trimethoprimsulfamethoxazole: a cohort study using health care database codes for 393,039 older women with urinary tract infections Am J Kidney Dis 57 2011 521 523
36. R.G. Cumming, D.G. Le Couteur Benzodiazepines and risk of hip fractures in older people: a review of the evidence CNS Drugs 17 2003 825 837 (Pubitemid 37082985)
37. B. Takkouche, A. MontesMartinez, S.S. Gill, M. Etminan Psychotropic medications and the risk of fracture: a metaanalysis Drug Saf 30 2007 171 184 (Pubitemid 46193066)
38. P.S. Wang, R.L. Bohn, R.J. Glynn et al. Zolpidem use and hip fractures in older people J Am Geriatr Soc 49 2001 1685 1690 (Pubitemid 34007997)
39. D.D. French, T.N. Chirikos, A. Spehar et al. Effect of concomitant use of benzodiazepines and other drugs on the risk of injury in a veterans population Drug Saf 28 2005 1141 1150 (Pubitemid 41776004)
40. P. Periti, T. Mazzei, E. Mini, A. Novelli Pharmacokinetic drug interactions of macrolides Clin Pharmacokinet 23 1992 106 131
41. D.A. Sica Interaction of grapefruit juice and calcium channel blockers Am J Hypertens 19 2006 768 773 (Pubitemid 43928515)
42. J.F. Westphal Macrolide-induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin Br J Clin Pharmacol 50 2000 285 295
43. D.R. Abernethy, J.B. Schwartz, E.L. Todd et al. Verapamil pharmacodynamics and disposition in young and elderly hypertensive patients Altered electrocardiographic and hypotensive responses Ann Intern Med 105 1986 329 336 (Pubitemid 16014294)
44. J.B. Schwartz Aging alters verapamil elimination and dynamics: single dose and steadystate responses J Pharmacol Exp Ther 255 1990 364 373 (Pubitemid 20361527)
45. S. Eberl, B. Renner, A. Neubert et al. Role of pglycoprotein inhibition for drug interactions: evidence from in vitro and pharmacoepidemiological studies Clin Pharmacokinet 46 2007 1039 1049 (Pubitemid 350136910)
46. E.M. Grandjean, J.M. Aubry Lithium: updated human knowledge using an evidencebased approach Part II: Clinical pharmacology and therapeutic monitoring CNS Drugs 23 2009 331 349
47. P. Blanche, E. Raynaud, D. Kerob, N. Galezowski Lithium intoxication in an elderly patient after combined treatment with losartan Eur J Clin Pharmacol 52 1997 501 (Pubitemid 27395651)
48. M. Leung, R.A. Remick Potential drug interaction between lithium and valsartan J Clin Psychopharmacol 20 2000 392 393 (Pubitemid 30318376)
49. P. Zwanzger, A. Marcuse, R.J. Boerner et al. Lithium intoxication after administration of AT1 blockers J Clin Psychiatry 62 2001 208 209
50. X. Wen, J.S. Wang, J.T. Backman et al. Trimethoprim and sulfamethoxazole are selective inhibitors of CYP2C8 and CYP2C9, respectively Drug Metab Dispos 30 2002 631 635 (Pubitemid 34579094)
51. L.A. Bauer, R.A. Blouin Age and phenytoin kinetics in adult epileptics Clin Pharmacol Ther 31 1982 301 304 (Pubitemid 12125448)
52. D. Battino, D. Croci, D. Mamoli et al. Influence of aging on serum phenytoin concentrations: a pharmacokinetic analysis based on therapeutic drug monitoring data Epilepsy Res 59 2004 155 165 (Pubitemid 38887687)
53. A. Holstein, W. Beil Oral antidiabetic drug metabolism: pharmacogenomics and drug interactions Expert Opin Drug Metab Toxicol 5 2009 225 241
54. Facts & Comparisons eAnswers Wolters Kluwer Health http://online.factsandcomparisons.com/index.aspx? 2011 Accessed March 1, 2011
55. Micromedex 2.0 Thomson Reuters http://www.thomsonhc.com/micromedex2/ librarian Accessed March 1, 2011
56. P.D. Hansten, J.R. Horn Drug Interactions Analysis and Management 2010 Wolters Kluwer Health, Inc St Louis, Mo
57. J.J. Lilja, M. Niemi, H. Fredrikson, P.J. Neuvonen Effects of clarithromycin and grapefruit juice on the pharmacokinetics of glibenclamide Br J Clin Pharmacol 63 2007 732 740 (Pubitemid 46753573)
58. K.L. LaPlante, T.L. Mersfelder, K.E. Ward, B.J. Quilliam Prevalence of and risk factors for dysglycemia in patients receiving gatifloxacin and levofloxacin in an outpatient setting Pharmacotherapy 28 2008 82 89
59. S.L. Aspinall, C.B. Good, R. Jiang et al. Severe dysglycemia with the fluoroquinolones: a class effect? Clin Infect Dis 49 2009 402 408
60. R.J. Lewis, J.F. Mohr III Dysglycaemias and fluoroquinolones Drug Saf 31 2008 283 292 (Pubitemid 351441577)
61. K. Sideras, J.N. Ingle, M.M. Ames et al. Coprescription of tamoxifen and medications that inhibit CYP2D6 J Clin Oncol 28 2010 2768 2776
62. M.P. Goetz, J.M. Rae, V.J. Suman et al. Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes J Clin Oncol 23 2005 9312 9318
63. W. Schroth, L. Antoniadou, P. Fritz et al. Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes J Clin Oncol 25 2007 5187 5193 (Pubitemid 350232249)
64. W. Schroth, M.P. Goetz, U. Hamann et al. Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen JAMA 302 2009 1429 1436
65. M.P. Goetz, S.K. Knox, V.J. Suman et al. The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen Breast Cancer Res Treat 101 2007 113 121 (Pubitemid 47555336)
66. R.A. Prince, E. Casabar, C.G. Adair et al. Effect of quinolone antimicrobials on theophylline pharmacokinetics J Clin Pharmacol 29 1989 650 654 (Pubitemid 19199825)
67. Z.Y. Zhang, L.S. Kaminsky Characterization of human cytochromes P450 involved in theophylline 8hydroxylation Biochem Pharmacol 50 1995 205 211
68. K.T. Batty, T.M. Davis, K.F. Ilett et al. The effect of ciprofloxacin on theophylline pharmacokinetics in healthy subjects Br J Clin Pharmacol 39 1995 305 311
69. K. ShakeriNejad, R. Stahlmann Drug interactions during therapy with three major groups of antimicrobial agents Expert Opin Pharmacother 7 2006 639 651
70. M.B. Bader Role of ciprofloxacin in fatal seizures Chest 101 1992 883 884
71. C.N. Sessler Theophylline toxicity: clinical features of 116 consecutive cases Am J Med 88 1990 567 576 (Pubitemid 20192267)
72. T.H. Self, C.C. Chafin, J.E. Soberman Effect of disease states on theophylline serum concentrations: are we still vigilant? Am J Med Sci 319 2000 177 182 (Pubitemid 30395202)
73. A.M. Holbrook, J.A. Pereira, R. Labiris et al. Systematic overview of warfarin and its drug and food interactions Arch Intern Med 165 2005 1095 1106 (Pubitemid 40720733)
74. L.S. Kaminsky, Z.Y. Zhang Human P450 metabolism of warfarin Pharmacol Ther 73 1997 67 74 (Pubitemid 26425815)
75. The use of oral anticoagulants (warfarin) in older people American Geriatrics Society guideline J Am Geriatr Soc 50 2002 1439 1445
76. R.I. Shorr, W.A. Ray, J.R. Daugherty, M.R. Griffin Concurrent use of nonsteroidal antiinflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease Arch Intern Med 153 1993 1665 1670 (Pubitemid 23217872)
77. M. Hauta-Aho, T. Tirkkonen, T. Vahlberg, K. Laine The effect of drug interactions on bleeding risk associated with warfarin therapy in hospitalized patients Ann Med 41 2009 619 628
78. F. Penning-van Beest, J. Erkens, K.U. Petersen et al. Main comedications associated with major bleeding during anticoagulant therapy with coumarins Eur J Clin Pharmacol 61 2005 439 444 (Pubitemid 41569322)
79. D.C. Malone, D.S. Hutchins, H. Haupert et al. Assessment of potential drugdrug interactions with a prescription claims database Am J Health Syst Pharm 62 2005 1983 1991 (Pubitemid 41416234)
80. F.L. Lanza, F.K. Chan, E.M. Quigley Guidelines for prevention of NSAID-related ulcer complications Am J Gastroenterol 104 2009 728 738
81. D.L. Bhatt, J. Scheiman, N.S. Abraham et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents Circulation 118 2008 1894 1909
82. R. Schellander, J. Donnerer Antidepressants: clinically relevant drug interactions to be considered Pharmacology 86 2010 203 215
83. W.V. Vieweg, M.A. Wood, A. Fernandez et al. Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly Drugs Aging 26 2009 997 1012
84. L. Urichuk, T.I. Prior, S. Dursun, G. Baker Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drugdrug interactions Curr Drug Metab 9 2008 410 418 (Pubitemid 352025195)
85. H.T. Taipale, S. Hartikainen, J.S. Bell A comparison of four methods to quantify the cumulative effect of taking multiple drugs with sedative properties Am J Geriatr Pharmacother 8 2010 460 471
86. N. Campbell, M. Boustani, T. Limbil et al. The cognitive impact of anticholinergics: a clinical review Clin Interv Aging 4 2009 225 233
87. D.C. Malone, J. Abarca, P.D. Hansten et al. Identification of serious drugdrug interactions: results of the partnership to prevent drugdrug interactions J Am Pharm Assoc (2003) 44 2004 142 151
88. C. Zhan, R. CorreadeAraujo, A.S. Bierman et al. Suboptimal prescribing in elderly outpatients: potentially harmful drugdrug and drugdisease combinations J Am Geriatr Soc 53 2005 262 267 (Pubitemid 41632552)
89. Top ten dangerous drug interactions in long-term care http://www.amda.com/tools/clinical/m3/topten.cfm Accessed September 29, 2011
90. Quality measures: overview https://www.cms.gov/qualitymeasures/ Accessed September 29, 2011
91. State operations provider certification CMS Manual System Publication No. 10007 http://www.cms.gov/transmittals/downloads/R22SOMA.pdf Accessed September 29, 2011